<DOC>
	<DOCNO>NCT01938547</DOCNO>
	<brief_summary>To evaluate efficacy , safety dose intravenous ( IV ) infusion clevidipine blood pressure ( BP ) management pediatric patient perioperative setting .</brief_summary>
	<brief_title>Assessment Efficacy , Safety Dosing Clevidipine Pediatric Patients Undergoing Surgery ( PIONEER )</brief_title>
	<detailed_description>This open label study ass , stepwise approach across 4 age cohort oldest young ( birth &lt; age 18 ) , efficacy safety clevidipine exposure minimum 30 minute maximum 96 hour pediatric patient undergo surgical procedure anesthesia great equal 1 hour parenteral intravenous antihypertensive therapy management blood pressure expect .</detailed_description>
	<mesh_term>Clevidipine</mesh_term>
	<criteria>Less 18 year age Written inform consent obtain initiation studyrelated procedure The enrol physician determines patient likely require 15 % reduction BP perioperative course Intraarterial line available blood pressure monitor Surgical procedure require minimum 1 hour anesthesia , IV antihypertensive therapy control BP least 30 minute anticipate Administration IV oral antihypertensive agent within 2 hour prior study drug administration Congenital heart disease describe single ventricle Evidence liver failure , severe liver disease , pulmonary disease ( e.g . uncontrolled asthma ) , hyperlipidemia , lipoid nephrosis , lipid dysfunction acute pancreatitis Allergy soya bean oil egg lecithin Known intolerant calcium channel blocker Hemophilia blood coagulation disorder Any serious medical condition , opinion investigator , likely interfere study procedure Clinically significant abnormal physical finding screen evaluation Any serious surgical medical condition , opinion investigator , likely interfere study procedure pharmacokinetics pharmacodynamics study drug Patient terminally ill ( death likely occur within 48 hour ) Use Methylphenidate , calcium channel blocker , Aripiprazole atypical anti psychotic antihypertensive use BP control within 2 hour prior study drug initiation Positive serum urine pregnancy test female child bear potential Participation clinical research study involve evaluation investigational drug device within 30 day enrollment Patients , reason , deem Investigator inappropriate study Subject relative Investigator his/her deputy , research assistant , pharmacist , study coordinator , staff directly involve conduct study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>perioperative</keyword>
	<keyword>blood pressure</keyword>
	<keyword>pediatrics</keyword>
	<keyword>pediatric surgery</keyword>
</DOC>